Shennon Biotechnologies
About:
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Website: https://www.shennonbio.com/
Top Investors: Mei Z., DCVC, Foundation Capital, AV8 Ventures, Jasper Lau
Description:
Shennon Biotechnologies analyzes and manipulates a massive number of cells on the single-cell level to develop more effective treatments for human diseases. It functionally profiles millions of immune cells to find the best targets for cancer immunotherapy.
Total Funding Amount:
$13M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2021-04-01
Founders:
Li Sun
Number of Employees:
11-50
Last Funding Date:
2023-03-13
IPO Status:
Private
Industries:
© 2025 bioDAO.ai